Edwards Lifesciences and Medtronic may be on top of the heart valve market, but with about a dozen new device slated to hit the market in the coming years, their competition is about to get a lot stiffer.
It's not your father's transcatheter aortic valve implant anymore.
Next year and the year after, the competitive landscape for TAVI will explode, with as many as 12 competing devices on the market here and across the pond.
And that competition will be fierce. As TAVI celebrates its 10th birthday,at least 1 analyst is predicting a 20%+ compound annual growth rate for the market, which she says could potentially double by 2015.